by The eClinical Solutions market is expected to reach USD 16.36 billion by 2027, with a CAGR of 13.6% during the forecast period 2020 – 2027.
The report provides an analysis of the global eClinical Solutions market for the period of 2016 to 2027, wherein the period from 2020 to 2027 comprises the forecast period and 2019 is the base year. Data for 2018 is provided as historical information.
The report covers all the major trends and technologies playing a major role in the growth of the eClinical Solutions market over the forecast period. It also highlights various drivers, restraints and opportunities expected to influence the market’s growth during the forecast period. The study provides a holistic perspective on the market’s growth in terms of revenue in US$ Mn, across different geographical regions namely North America, Europe, Asia Pacific, Middle East & Africa and Latin America.
Request Coronavirus Impact Analysis on this Market@ https://www.precedenceresearch.com/sample/1092
Scope of the Report
The market overview section of the report showcases the market dynamics and trends such as the drivers, restraints and opportunities that influence the current nature and future status of this market. The report also provides value chain analysis and key market indicators. The global market estimates are the result of our in-depth secondary research, primary interviews and in-house expert panel reviews. These market estimates have been analyzed by taking into account the impact of different political, social, economic, technological and legal factors along with the current market dynamics affecting the market growth.
For relevant insights, the eClinical Solutions market has been segmented into 5 broader regions. Trends prevalent across prominent countries of every region have been studied from seller as well as buyer perspective. The demand for every product and application varies from region to region and the same has been correctly captured by the author of report. The reader of report would be able to make critical decisions related to cross border expansion, new product launch and so on.
The market competition has been analyzed and shares held by prominent companies have been estimated. The profiles of global leading companies are described in the report. Inclusions of company profile are the overview, offerings portfolio, financial performance, strategy adopted and relevant recent collaborations. All this put together, would help the reader of report in making important business decisions.
For a better understanding of the global eClinical Solutions market, analysts have segmented the market. The segmentation has been done on the basis of
Market Segmentation:
By Product
- EDC & CDMS
- eCOA
- Clinical Data Integration Platforms
- CTMS
- Safety Solutions
- RTSM
- Clinical Analytics platforms
- eTMF
By Development Phase
- Phase IV
- Phase III
- Phase II
- Phase I
By Delivery Mode
- Licensed Enterprise
- Web-hosted
- Cloud-based
By End-Use
- CROs
- Hospitals
- Academic Institutes
- Medical Device Manufacturers
- Pharma & Biotech Organizations
By Regional Outlook
- North America
- U.S.
- Canada
- Europe
- U.K.
- Germany
- France
- Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of the World
Regional Segmentation:
The global version of this report with a geographical classification such as North America, Europe, Asia Pacific, Middle East and Africa and Latin America. These key regions focus on the consumption of eClinical Solutions market. The creators of the report have studied the region’s growth potential to assist organizations in arranging their future investments. They also study the regulatory reforms and norms that are expected to impact the global market.
Get Customization on This Report@ https://www.precedenceresearch.com/customization/1092
Competitive Dynamics
The report also includes competitive profiling of the key players associated with the eClinical Solutions market around the globe. The important business strategies adopted by them, their market positioning, financials, SWOT analysis and recent developments have also been identified in the research report. The competitive landscape section of the report also gives an overview about the major contributing regions/countries by these key players in order to strengthen their market position in the future.
Technology advancement and rising medical application in 3D printing across emerging economies, are forcing companies to develop eClinical Solutions to continue the profitability of the market.
Company Profiles: Almost all major players of the global eClinical Solutions market is profiled in this report. The creators of the report have provided information about their recent developments in eClinical Solutions market, products, revenue, production, business, and company.
Target audience of the global eClinical Solutions market in market study:
- PAREXEL International
- Oracle Corp.
- Bioclinica
- Medidata Solution
- DATATRAK
- ERT Clinical
- CRF Health
- eClinicalWorks
- OmniComm Systems
- IBM Watson Health
- eClinical Solutions
Table of Content
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
Chapter 5. Market Dynamics Analysis and Trends
5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition
Chapter 6. Competitive Landscape
6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers
Chapter 7. Global eClinical Solutions Market, By Product
7.1. eClinical Solutions Market, by Product Type, 2020-2027
7.1.1. EDC & CDMS
7.1.1.1. Market Revenue and Forecast (2016-2027)
7.1.2. eCOA
7.1.2.1. Market Revenue and Forecast (2016-2027)
7.1.3. Clinical Data Integration Platforms
7.1.3.1. Market Revenue and Forecast (2016-2027)
7.1.4. CTMS
7.1.4.1. Market Revenue and Forecast (2016-2027)
7.1.5. Safety Solutions
7.1.5.1. Market Revenue and Forecast (2016-2027)
7.1.6. RTSM
7.1.6.1. Market Revenue and Forecast (2016-2027)
7.1.7. Clinical Analytics platforms
7.1.7.1. Market Revenue and Forecast (2016-2027)
7.1.8. eTMF
7.1.8.1. Market Revenue and Forecast (2016-2027)
Chapter 8. Global eClinical Solutions Market, By Development Phase
8.1. eClinical Solutions Market, by Development Phase, 2020-2027
8.1.1. Phase IV
8.1.1.1. Market Revenue and Forecast (2016-2027)
8.1.2. Phase III
8.1.2.1. Market Revenue and Forecast (2016-2027)
8.1.3. Phase II
8.1.3.1. Market Revenue and Forecast (2016-2027)
8.1.4. Phase I
8.1.4.1. Market Revenue and Forecast (2016-2027)
Chapter 9. Global eClinical Solutions Market, By Delivery Mode
9.1. eClinical Solutions Market, by Delivery Mode, 2020-2027
9.1.1. Licensed Enterprise
9.1.1.1. Market Revenue and Forecast (2016-2027)
9.1.2. Web-hosted
9.1.2.1. Market Revenue and Forecast (2016-2027)
9.1.3. Cloud-based
9.1.3.1. Market Revenue and Forecast (2016-2027)
Chapter 10. Global eClinical Solutions Market, By End-Use
10.1. eClinical Solutions Market, by End-Use, 2020-2027
10.1.1. CROs
10.1.1.1. Market Revenue and Forecast (2016-2027)
10.1.2. Hospitals
10.1.2.1. Market Revenue and Forecast (2016-2027)
10.1.3. Academic Institutes
10.1.3.1. Market Revenue and Forecast (2016-2027)
10.1.4. Medical Device Manufacturers
10.1.4.1. Market Revenue and Forecast (2016-2027)
10.1.5. Pharma & Biotech Organizations
10.1.5.1. Market Revenue and Forecast (2016-2027)
Chapter 11. Global eClinical Solutions Market, Regional Estimates and Trend Forecast
11.1. North America
11.1.1. Market Revenue and Forecast, by Product (2016-2027)
11.1.2. Market Revenue and Forecast, by Development Phase (2016-2027)
11.1.3. Market Revenue and Forecast, by Delivery Mode (2016-2027)
11.1.4. Market Revenue and Forecast, by End-Use (2016-2027)
11.1.5. U.S.
11.1.5.1. Market Revenue and Forecast, by Product (2016-2027)
11.1.5.2. Market Revenue and Forecast, by Development Phase (2016-2027)
11.1.5.3. Market Revenue and Forecast, by Delivery Mode (2016-2027)
11.1.5.4. Market Revenue and Forecast, by End-Use (2016-2027)
11.1.6. Rest of North America
11.1.6.1. Market Revenue and Forecast, by Product (2016-2027)
11.1.6.2. Market Revenue and Forecast, by Development Phase (2016-2027)
11.1.6.3. Market Revenue and Forecast, by Delivery Mode (2016-2027)
11.1.6.4. Market Revenue and Forecast, by End-Use (2016-2027)
11.2. Europe
11.2.1. Market Revenue and Forecast, by Product (2016-2027)
11.2.2. Market Revenue and Forecast, by Development Phase (2016-2027)
11.2.3. Market Revenue and Forecast, by Delivery Mode (2016-2027)
11.2.4. Market Revenue and Forecast, by End-Use (2016-2027)
11.2.5. UK
11.2.5.1. Market Revenue and Forecast, by Product (2016-2027)
11.2.5.2. Market Revenue and Forecast, by Development Phase (2016-2027)
11.2.5.3. Market Revenue and Forecast, by Delivery Mode (2016-2027)
11.2.5.4. Market Revenue and Forecast, by End-Use (2016-2027)
11.2.6. Germany
11.2.6.1. Market Revenue and Forecast, by Product (2016-2027)
11.2.6.2. Market Revenue and Forecast, by Development Phase (2016-2027)
11.2.6.3. Market Revenue and Forecast, by Delivery Mode (2016-2027)
11.2.6.4. Market Revenue and Forecast, by End-Use (2016-2027)
11.2.7. France
11.2.7.1. Market Revenue and Forecast, by Product (2016-2027)
11.2.7.2. Market Revenue and Forecast, by Development Phase (2016-2027)
11.2.7.3. Market Revenue and Forecast, by Delivery Mode (2016-2027)
11.2.7.4. Market Revenue and Forecast, by End-Use (2016-2027)
11.2.8. Rest of Europe
11.2.8.1. Market Revenue and Forecast, by Product (2016-2027)
11.2.8.2. Market Revenue and Forecast, by Development Phase (2016-2027)
11.2.8.3. Market Revenue and Forecast, by Delivery Mode (2016-2027)
11.2.8.4. Market Revenue and Forecast, by End-Use (2016-2027)
11.3. APAC
11.3.1. Market Revenue and Forecast, by Product (2016-2027)
11.3.2. Market Revenue and Forecast, by Development Phase (2016-2027)
11.3.3. Market Revenue and Forecast, by Delivery Mode (2016-2027)
11.3.4. Market Revenue and Forecast, by End-Use (2016-2027)
11.3.5. India
11.3.5.1. Market Revenue and Forecast, by Product (2016-2027)
11.3.5.2. Market Revenue and Forecast, by Development Phase (2016-2027)
11.3.5.3. Market Revenue and Forecast, by Delivery Mode (2016-2027)
11.3.5.4. Market Revenue and Forecast, by End-Use (2016-2027)
11.3.6. China
11.3.6.1. Market Revenue and Forecast, by Product (2016-2027)
11.3.6.2. Market Revenue and Forecast, by Development Phase (2016-2027)
11.3.6.3. Market Revenue and Forecast, by Delivery Mode (2016-2027)
11.3.6.4. Market Revenue and Forecast, by End-Use (2016-2027)
11.3.7. Japan
11.3.7.1. Market Revenue and Forecast, by Product (2016-2027)
11.3.7.2. Market Revenue and Forecast, by Development Phase (2016-2027)
11.3.7.3. Market Revenue and Forecast, by Delivery Mode (2016-2027)
11.3.7.4. Market Revenue and Forecast, by End-Use (2016-2027)
11.3.8. Rest of APAC
11.3.8.1. Market Revenue and Forecast, by Product (2016-2027)
11.3.8.2. Market Revenue and Forecast, by Development Phase (2016-2027)
11.3.8.3. Market Revenue and Forecast, by Delivery Mode (2016-2027)
11.3.8.4. Market Revenue and Forecast, by End-Use (2016-2027)
11.4. MEA
11.4.1. Market Revenue and Forecast, by Product (2016-2027)
11.4.2. Market Revenue and Forecast, by Development Phase (2016-2027)
11.4.3. Market Revenue and Forecast, by Delivery Mode (2016-2027)
11.4.4. Market Revenue and Forecast, by End-Use (2016-2027)
11.4.5. GCC
11.4.5.1. Market Revenue and Forecast, by Product (2016-2027)
11.4.5.2. Market Revenue and Forecast, by Development Phase (2016-2027)
11.4.5.3. Market Revenue and Forecast, by Delivery Mode (2016-2027)
11.4.5.4. Market Revenue and Forecast, by End-Use (2016-2027)
11.4.6. North Africa
11.4.6.1. Market Revenue and Forecast, by Product (2016-2027)
11.4.6.2. Market Revenue and Forecast, by Development Phase (2016-2027)
11.4.6.3. Market Revenue and Forecast, by Delivery Mode (2016-2027)
11.4.6.4. Market Revenue and Forecast, by End-Use (2016-2027)
11.4.7. South Africa
11.4.7.1. Market Revenue and Forecast, by Product (2016-2027)
11.4.7.2. Market Revenue and Forecast, by Development Phase (2016-2027)
11.4.7.3. Market Revenue and Forecast, by Delivery Mode (2016-2027)
11.4.7.4. Market Revenue and Forecast, by End-Use (2016-2027)
11.4.8. Rest of MEA
11.4.8.1. Market Revenue and Forecast, by Product (2016-2027)
11.4.8.2. Market Revenue and Forecast, by Development Phase (2016-2027)
11.4.8.3. Market Revenue and Forecast, by Delivery Mode (2016-2027)
11.4.8.4. Market Revenue and Forecast, by End-Use (2016-2027)
11.5. Latin America
11.5.1. Market Revenue and Forecast, by Product (2016-2027)
11.5.2. Market Revenue and Forecast, by Development Phase (2016-2027)
11.5.3. Market Revenue and Forecast, by Delivery Mode (2016-2027)
11.5.4. Market Revenue and Forecast, by End-Use (2016-2027)
11.5.5. Brazil
11.5.5.1. Market Revenue and Forecast, by Product (2016-2027)
11.5.5.2. Market Revenue and Forecast, by Development Phase (2016-2027)
11.5.5.3. Market Revenue and Forecast, by Delivery Mode (2016-2027)
11.5.5.4. Market Revenue and Forecast, by End-Use (2016-2027)
11.5.6. Rest of LATAM
11.5.6.1. Market Revenue and Forecast, by Product (2016-2027)
11.5.6.2. Market Revenue and Forecast, by Development Phase (2016-2027)
11.5.6.3. Market Revenue and Forecast, by Delivery Mode (2016-2027)
11.5.6.4. Market Revenue and Forecast, by End-Use (2016-2027)
Chapter 12. Company Profiles
12.1. PAREXEL International
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. Oracle Corp.
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. Bioclinica
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. Medidata Solution
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. DATATRAK
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. ERT Clinical
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
12.7. CRF Health
12.7.1. Company Overview
12.7.2. Product Offerings
12.7.3. Financial Performance
12.7.4. Recent Initiatives
12.8. eClinicalWorks
12.8.1. Company Overview
12.8.2. Product Offerings
12.8.3. Financial Performance
12.8.4. Recent Initiatives
12.9. OmniComm Systems
12.9.1. Company Overview
12.9.2. Product Offerings
12.9.3. Financial Performance
12.9.4. Recent Initiatives
12.10. IBM Watson Health
12.10.1. Company Overview
12.10.2. Product Offerings
12.10.3. Financial Performance
12.10.4. Recent Initiatives
12.11. eClinical Solutions
12.11.1. Company Overview
12.11.2. Product Offerings
12.11.3. Financial Performance
12.11.4. Recent Initiatives
Chapter 13. Research Methodology
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
Chapter 14. Appendix
14.1. About Us
14.2. Glossary of Terms
Get Full Access of This Research Report@ https://www.precedenceresearch.com/checkout/1092
Contact Us:
Precedence Research
Apt 1408 1785 Riverside Drive Ottawa, ON, K1G 3T7, Canada
Call: +1 774 402 6168
Email: sales@precedenceresearch.com
Website: https://www.precedenceresearch.com
